Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN.DL)
CAPS Rating:
A biopharmaceutical company committed to improving the lives of people with diabetes, obesity and other diseases through the discovery, development and commercialization of innovative medicines.
RSS Headlines
Fool UK
Recs
Take over target if I needed access to one of the best line-ups of futures hits in the product pipeline world I would aquire AMLN.